Sorrento Therapeutics News

Sorrento Therapeutics | 8-K: Current report

Nov 8, 2023 05:34

Sorrento Therapeutics | 8-K: Current report

Nov 4, 2023 05:31

Sorrento Therapeutics | 8-K: Current report

Oct 28, 2023 04:15

Sorrento Therapeutics | 8-K: Current report

Oct 6, 2023 05:26

Sorrento Therapeutics | 8-K: Current report

Sep 27, 2023 04:54

Sorrento Therapeutics | 8-K: Current report

Sep 13, 2023 09:51

Sorrento Therapeutics | 8-K: Current report

Aug 29, 2023 05:25

Sorrento Therapeutics | 8-K: Current report

Aug 21, 2023 23:20

Sorrento Therapeutics | 8-K: Current report

Aug 11, 2023 04:14

Sorrento Therapeutics | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Aug 8, 2023 04:15

Sorrento Therapeutics | 8-K: Current report

Aug 1, 2023 18:01

Sorrento Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Jul 19, 2023 05:23

Sorrento Therapeutics | 8-K: Current report

Jul 13, 2023 18:26

Sorrento Therapeutics | 8-K: Current report

Jul 8, 2023 09:49

Sorrento Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Jun 22, 2023 05:24

Sorrento Therapeutics | 8-K: Current report

Jun 21, 2023 05:01

Sorrento Therapeutics | 8-K: Current report

Jun 15, 2023 21:41

Sorrento Therapeutics | 8-K: Current report

May 19, 2023 09:23

Sorrento Therapeutics | 8-K: Current report

May 16, 2023 00:03

Sorrento Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

May 13, 2023 05:28